Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
Skip to main content
Donate

Let's beat cancer sooner

Blank Avatar

Emma studied biochemistry at Imperial College London then stayed on for a Masters and PhD on her favourite topic, immunology. After almost a decade there, she braved the move out of London (a whole 12 miles south) and joined The Institute of Cancer Research to study multiple myeloma, a white blood cell cancer. She left the lab for the final time in 2010 and, after a couple of years at Breakthrough Breast Cancer, joined the Science Communications team at Cancer Research UK.

When defences attack: the hidden cause of cancer hiding in our cells

Category: Science blog May 12, 2015

Last month, we wrote about Cancer Research UK-funded scientists at The Francis Crick Institute, whose research is tracing the origins of the genetic diversity ...

Read More

Alternative therapies: what’s the harm?

Category: Science blog April 27, 2015

We often see stories in the media about cancer patients who have chosen alternative treatments, either alongside or instead of conventional treatment. Every can...

Read More

Migration, settlement, and more migration: how prostate cancers spread

Category: Science blog April 1, 2015

We explore new research tracing the origins of prostate cancer and how the disease spreads around the body.

Read More

The HOPON clinical trial: a patient’s view

Category: Science blog January 9, 2015

In the final post in our series about the HOPON clinical trial, we hear from a patient who recently took part in the research, Gerard Dean.

Read More

The HOPON clinical trial: the research nurses’ role

Category: Science blog January 8, 2015

In the second installment of our series on the HOPON clinical trial we hear from the research nurses who help to run the trial in Liverpool.

Read More

The HOPON clinical trial: the doctor’s perspective

Category: Science blog January 7, 2015

In the first of a three-part series we hear from a doctor whose clinical trial was funded by Stand Up To Cancer in 2012.

Read More

Dances with Pharma: part 2 – How Cancer Research UK works with industry

Category: Science blog December 17, 2014

This entry is part 2 of 2 in the series Dances with Pharma

In the second part of this two-part series, we look at our work with industry, why it’s important, and how we try to influence the way drugs get to patients.

Read More